Nanopublications

Matches in Nanopublications for { ?s ?p "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

Showing items 1 to 15 of 15 with 100 items per page.

NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613323.RAb4nN1d6A_ic9BswM1vBaENfeg2iS4wxjMwDeel50ezc130_provenance.
NP503346.RAvs1h1XaqQQgunUViIQakx3tI7WPF5_4hAB7cDRcMTJ4130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP503346.RAvs1h1XaqQQgunUViIQakx3tI7WPF5_4hAB7cDRcMTJ4130_provenance.
NP549374.RA4KL4dduQdhs-Jg2nIE_13XEnvqqq5MArmxYYz3IfaJw130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549374.RA4KL4dduQdhs-Jg2nIE_13XEnvqqq5MArmxYYz3IfaJw130_provenance.
NP654274.RAzMla34Y6EZXXXKg2QJPLMTIkOKiBqeNfnFM0pCnJu0s130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP654274.RAzMla34Y6EZXXXKg2QJPLMTIkOKiBqeNfnFM0pCnJu0s130_provenance.
NP605924.RAe_GbUrXhKCeF_oeNftufAQXOAHnaAYUxhIlLIgDAu7o130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP605924.RAe_GbUrXhKCeF_oeNftufAQXOAHnaAYUxhIlLIgDAu7o130_provenance.
NP755309.RAKlGPpFgX6Sr-MvKTnLNnEvBbs7l8XEJNKcfMFq7Lrr4130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755309.RAKlGPpFgX6Sr-MvKTnLNnEvBbs7l8XEJNKcfMFq7Lrr4130_provenance.
NP978463.RACvSX9QPjUdUePO6xewrd2Opfn6X7lxtY69A5qx4Whxw130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978463.RACvSX9QPjUdUePO6xewrd2Opfn6X7lxtY69A5qx4Whxw130_provenance.
NP758929.RAe1jHmq947rSI7Mi0uezt8sowoJwzTaXgCGXlZIr1Ctw130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758929.RAe1jHmq947rSI7Mi0uezt8sowoJwzTaXgCGXlZIr1Ctw130_provenance.
NP758931.RAcKWY1HdwgabnMCdtI9mKUc1qocDMmOPpLCHWzOpEw0o130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758931.RAcKWY1HdwgabnMCdtI9mKUc1qocDMmOPpLCHWzOpEw0o130_provenance.
NP758926.RAhFKIowqgMKFdWlJ2nIIb6nMcrtcKVG0UBDyaKdSYf-k130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758926.RAhFKIowqgMKFdWlJ2nIIb6nMcrtcKVG0UBDyaKdSYf-k130_provenance.
NP758932.RAukFV1QXU1WhvHkUkg6aZHIKVkVXX0prDzshb4u2l2HE130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758932.RAukFV1QXU1WhvHkUkg6aZHIKVkVXX0prDzshb4u2l2HE130_provenance.
NP913951.RANdpoMUFAnKYvsZZhvZCkj2GXmpi0LMAfPwBOW8apgyo130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913951.RANdpoMUFAnKYvsZZhvZCkj2GXmpi0LMAfPwBOW8apgyo130_provenance.
NP781371.RAECeKay8kIxM6moU5_tYo7NDwI7-qOjr6bwaMByHpCxE130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781371.RAECeKay8kIxM6moU5_tYo7NDwI7-qOjr6bwaMByHpCxE130_provenance.
NP873122.RA_RjBBIE4SuZXnFuahn8EcYHeC57yj-DQCngIY07X7LU130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP873122.RA_RjBBIE4SuZXnFuahn8EcYHeC57yj-DQCngIY07X7LU130_provenance.
NP758927.RA7lI1NMA_Pet7sLvi3buefX2_urG4rEFHx9msCubBi_8130_assertion description "[Oncogenic mutations of gene RAS are most frequent and detected in 20% - 30% of human leukemias and 10% - 15% of MDS cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP758927.RA7lI1NMA_Pet7sLvi3buefX2_urG4rEFHx9msCubBi_8130_provenance.